Berberine inhibits the proliferation of HCC cell lines by suppressing c-myc-induced glutamine transporter SLC1A5, subsequently decreasing glutamine uptake (Zhang et al., 2019). The gene discussed is SLC1A5; the disease is hepatocellular carcinoma.